Evidence map›Paper›PMID 33918312›Full record

ArticleInternational journal of molecular sciences2021

Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.

Ssu-Yu Chen, Yung-Lung Chang, Shu-Ting Liu, Gunng-Shinng Chen, Shiao-Pieng Lee, Shih-Ming Huang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Advances in Small Molecular Agents against Oral Cancer.Molecules (Basel, Switzerland) · 2024
    Review
  12. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ssu-Yu ChenDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.
Yung-Lung ChangDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.
Shu-Ting LiuDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.
Gunng-Shinng ChenSchool of Dentistry, Department of Dentistry of Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan.
Shiao-Pieng LeeSchool of Dentistry, Department of Dentistry of Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan.ORCID 0000-0002-7345-2062
Shih-Ming HuangDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.ORCID 0000-0001-9305-921X
National Defense Medical Center · TWTri-Service General Hospital · TW

Funding

Ministry of National Defense-Medical Affairs Bureau, Taiwan MND-MAB-110-089Tri-Service General Hospital, Taipei, Taiwan TSGH-D-110064 and TSGH-E-110207
6 · The paper itself

Abstract

Disulfiram (DSF), an irreversible aldehyde dehydrogenase inhibitor, is being used in anticancer therapy, as its effects in humans are known and less adverse than conventional chemotherapy. We explored the potential mechanism behind the cytotoxicity of DSF-Cu

Indexed as

Acetaldehyde Dehydrogenase InhibitorsCarcinoma, Squamous CellCopperDisulfiramDrug RepositioningDrug Screening Assays, AntitumorHumansHypoxia-Inducible Factor 1, alpha SubunitMitochondriaMouth NeoplasmsPrimary Cell CultureProto-Oncogene Proteins c-mycAcetaldehyde Dehydrogenase InhibitorsCopperDisulfiramHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitMYC protein, humanProto-Oncogene Proteins c-mycc-MyccopperdisulfiramHIF-1αreactive oxygen species

Identifiers

PMID33918312
PMCPMC8038175
OpenAlexW3149563325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.